نتایج جستجو برای: hematologic stem cell transplantation

تعداد نتایج: 1903173  

Journal: :Annals of internal medicine 2004
Martha Skinner Vaishali Sanchorawala David C Seldin Laura M Dember Rodney H Falk John L Berk Jennifer J Anderson Carl O'Hara Kathleen T Finn Caryn A Libbey Janice Wiesman Karen Quillen Niall Swan Daniel G Wright

BACKGROUND AL amyloidosis is a fatal disease resulting from tissue deposition of amyloid fibrils derived from monoclonal immunoglobulin light chains. Treatment with oral chemotherapy is minimally effective. OBJECTIVE To test survival and organ response in a large sample of patients treated with high-dose intravenous melphalan (100 to 200 mg/m2) and autologous blood stem-cell transplantation. ...

Journal: :Hamostaseologie 2012
G Stussi D A Tsakiris

Allogeneic and autologous hematopoietic stem cell transplantations are important therapeutic options for patients with hematologic disorders. Hemostatic complications are frequent after hematopoietic stem cell transplantation with a considerable morbidity and mortality. The incidence of bleedings and thrombosis is highest in the first few weeks after transplantation, but may also occur later. H...

Journal: :Haematologica 2000
C Pérez-Caballero M S Maldonado R Tamariz J P de Oteyza A Muñoz

plantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor. Blood 1995; 85:1666-72. 5. Elmaagacli AH, Beelen DW, Becks HW, et al. Molecular studies of chimerism and minimal residual disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation. Bone Marrow Transplant 1996; 18:397-403. 6. Schwartzberg L, Bi...

Journal: :Archives of Iranian medicine 2006
Mojgan Shaiegan Esmerdis Hadjati Mahnaz Aghaiipour Masoud Iravani Gaelle David Daniel Bernard

The aim of this study was to evaluate mixed red cells population and red blood cell chimerism after hematopoietic stem cell transplantation. Red blood cell chimerism after hematopoietic stem cell transplantation was analyzed using a series of fluorescein isothiocyanate-conjugated monoclonal antibodies (BioAtlantic, France) directed against ABH, Rh (D, C, E, c, e), Kell, Duffy, Kidd, and Ss anti...

آزاد, مهدی , اسکندری, فاطمه , اله‌وردی, امیر , سلیمانی, مسعود , کلانتری, نسیم ,

Background: Hematopoietic stem cell transplantation (HSCT) is a therapeutic approach in treatment of hematologic malignancies and incompatibility of bone marrow. Umbilical cord blood (UCB) known as an alternative for hematopoietic stem/ progenitor cells (HPSC) for in allogenic transplantation. The main hindrance in application of HPSC derived from umbilical cord blood is the low volume of colle...

Journal: :international journal of hematology-oncology and stem cell research 0
mohammad faizan zahid medical college, the aga khan university, karachi, pakistan. natasha ali departments of pathology & microbiology and oncology, the aga khan university, karachi, pakistan. mohammad usman shaikh departments of pathology & microbiology and oncology, the aga khan university, karachi, pakistan. salman naseem adil departments of pathology & microbiology and oncology, the aga khan university, karachi, pakistan.

introduction: allogeneic hematopoietic stem cell transplantation is a potentially curative treatment modality for hematological malignancies. we evaluated the outcome of patients suffering from hematological malignancies, including acute leukemias, chronic myeloid leukemia and myelodysplastic syndrome after allogeneic transplantation. methods: all patients having hematological malignancies with...

Journal: :international journal of hematology-oncology and stem cell research 0
ardeshir ghavamzadeh hematology- oncology and stem cell research center, shariati hospital, tehran university of medical sciences, tehran, iran kamran alimogaddam hematology- oncology and stem cell research center, shariati hospital, tehran university of medical sciences, tehran, iran mohammad jahani hematology- oncology and stem cell research center, shariati hospital, tehran university of medical sciences, tehran, iran amirali hamidieh hematology- oncology and stem cell research center, shariati hospital, tehran university of medical sciences, tehran, iran seyed asadollah mousavi hematology- oncology and stem cell research center, shariati hospital, tehran university of medical sciences, tehran, iran masoud iravani hematology- oncology and stem cell research center, shariati hospital, tehran university of medical sciences, tehran, iran

introduction: this review reports the current results of hematopoietic stem cell transplantation (hsct) in patients who had received transplantation in the hematology-oncology and sct research center, tehran, iran. methods: in iran, from 1991 through 2010, a total of 3170 hematopoietic stem cell transplantation have been carried out. the male/female patient ratio was 1909/1261 with a median age...

Journal: :Aquichan 2021

Objective: To assess and correlate overall quality of life the cognitive function adult patients with hematologic cancer subjected to autologous allogeneic hematopoietic stem cell transplantations up three years after treatment. Materials method: A longitudinal, observational, analytical study was conducted 55 in a reference hospital Latin America, from September 2013 February 2019, Quality Lif...

Journal: :Biology of Blood and Marrow Transplantation 2010

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید